Vivesto AB (OASMY)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Feb 10, 2026
Vivesto AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
5.77M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.61M | 3.57M | 117.50% |
| Dec 31, 2022 | 3.04M | -25.83M | -89.47% |
| Dec 31, 2021 | 28.87M | 24.90M | 626.79% |
| Dec 31, 2020 | 3.97M | -202.23M | -98.07% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CV Sciences | 14.37M |
| CordovaCann | 10.20M |
| Tristar Wellness Solutions | 4.00M |
| Cannabis Bioscience International Holdings | 148.34K |
| Rafarma Pharmaceuticals | 133.33K |
| Full Alliance Group | 82.12K |
Vivesto AB News
- 2 months ago - Vivesto AB (OASMY) Discusses Pipeline Advancements in Paccal Vet and Cantrixil and Strategic Capital Raise Transcript - Seeking Alpha